Navigation Links
SynteractHCR Addressing Successful Ways to Approach Sponsor and CRO Collaboration at May Pharmaceutical Events in US and Europe
Date:5/2/2013

SAN DIEGO, May 2, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), will attend and present at two conferences in May, Outsourcing in Clinical Trials Southeast and Outsourcing in Clinical Trials Europe. Speakers Barbara Ruby and Dr. Sonja Weiser will address the relationship between sponsors and outsourced clinical research organizations and how their collaboration aids in the success of trials.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Outsourcing in Clinical Trials Southeast will take place in Raleigh-Durham, NC from May 7-8, 2013. SynteractHCR will exhibit at booth #22. Barbara Ruby , associate project director, will present "CRO/Sponsor Successful Collaboration: How to Effectively Work Together" at 2:00 p.m. EDT on May 7th. Ms. Ruby has more than 20 years of experience in clinical research including multiple roles as a study coordinator, sub-investigator, monitor and project manager at both CROs and biotech companies. Her presentation will include how to establish a clinical trial agreement that is clear and comprehensive, how to create team transparency from the outset, and how to manage the unexpected and establish accountability.

The third annual Outsourcing in Clinical Trials Europe will take place in Zurich, Switzerland from May 14-15, 2013. SynteractHCR will exhibit at booth #33. Dr. Sonja Weiser ,Regional Director, Nordic & East, will present "Applying Result-driven Techniques to Successfully Transition (and Save) a Failing Study" at 4:00 p.m. CET on May 14th. The presentation will include how to determine when a service provider is not performing and identify when a change in service provider is needed, how to select a new CRO, and how to facilitate a smooth transition that keeps the study on track. Dr. Weiser has more than 13 years of experience in the field of clinical research in pharma and biotech, as well as six years experience in an international CRO environment.

In March, 2013 SynteractHCR was formed from the merger of Synteract and Harrison Clinical Research (HCR), and operates from 16 locations worldwide to support large, later phase programs. To set up an appointment, contact Matt Smith , SVP sales and marketing at (760) 268-8200.

About SynteractHCR (www.synteracthcr.com)

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.

CONTACT:
Rachel Hutman
Rachel@clearpointagency.com
760-230-2424

 


'/>"/>
SOURCE SynteractHCR
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SynteractHCR Appoints Bill Pierce as Chief Information Officer and Richard Paul as Chief Medical Officer and Vice President Medical/Regulatory Affairs
2. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
3. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
4. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
5. Safe in Commons "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
6. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
10. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
11. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):